ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SERA vs AMS // EV/EBITDA & P/E VALUATION

Sera Prognostics Inc. (Class A) (NASDAQ) VS. American Shared Hospital Services (NYSE) • 15-METRIC TALLY: SERA 4 — AMS 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SERA VS. AMS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SERA AMS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% 18.00% -48.00 AMS /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -13.80% -21.20 AMS /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -12.80% -47.20 AMS /operating-margins <GO>
Net Profit Margin -60.00% -5.50% -54.50 AMS /net-margins <GO>
Revenue Growth (YoY) 5.20% -0.90% +6.10 SERA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 0.46 -0.26 AMS /balance-sheet <GO>
Piotroski F-Score Quality 4/9 3/9 +1.00 SERA /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 52.1 40.7 +11.40 SERA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $81.3M $8.4M $72.9M SERA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SERA REV AMS REV SERA GROSS % AMS GROSS % SERA FCF AMS FCF
FY 2025 $81.0K $28.1M -50.0% 18.0% -$26.3M -$4.5M
FY 2024 $77.0K $28.3M -6.5% 32.4% -$14.2M -$7.8M
FY 2023 $306.0K $21.3M — — -$27.2M $5.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SERA // BETA —
AMS // BETA —